215 related articles for article (PubMed ID: 34182815)
1. Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study.
Huang M; Han M; Han W; Kuang L
J Int Med Res; 2021 Jun; 49(6):3000605211025130. PubMed ID: 34182815
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of stress ulcer prophylaxis in septic patients: a retrospective cohort study based on large database].
Huang M; Kuang L; Han M; Han W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):641-647. PubMed ID: 34296679
[TBL] [Abstract][Full Text] [Related]
3. Stress ulcer prophylaxis in critically ill adult patients with sepsis at risk of gastrointestinal bleeding: a retrospective cohort study.
Huang M; Han M; Song Z; Kuang L
Intern Med J; 2023 Mar; 53(3):389-396. PubMed ID: 34697866
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitors Versus Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients: A Meta-analysis and Trial Sequential Analysis.
Deliwala SS; Hamid K; Goyal H; Ponnapalli A; Zayed Y; Bala A; Lakshman H; Malladi S; Jones S; Santana M; Leon B; An MT; Chawla S
J Clin Gastroenterol; 2022 Mar; 56(3):204-217. PubMed ID: 34049377
[TBL] [Abstract][Full Text] [Related]
5. Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock.
Barletta JF
Ann Pharmacother; 2014 Oct; 48(10):1276-81. PubMed ID: 24982312
[TBL] [Abstract][Full Text] [Related]
6. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
Boyd C; Hassig T; MacLaren R
Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Proton Pump Inhibitors vs Histamine Type 2 Receptor Blockers for Preventing Clinically Important Gastrointestinal Bleeding During Intensive Care: A Population-Based Study.
Lilly CM; Aljawadi M; Badawi O; Onukwugha E; Tom SE; Magder LS; Harris I
Chest; 2018 Sep; 154(3):557-566. PubMed ID: 29856970
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients.
Chen C; Liu H; Duan R; Wang F; Duan L
J Gastroenterol Hepatol; 2021 Aug; 36(8):2131-2140. PubMed ID: 33586808
[TBL] [Abstract][Full Text] [Related]
9. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
10. [Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].
Sun J; Wang B; Cao P; Zhu H; Lu K; Geng P; Tan D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):539-544. PubMed ID: 31198136
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial.
van Diepen S; Coulson T; Wang X; Opgenorth D; Zuege DJ; Harris J; Agyemang M; Niven DJ; Bellomo R; Wright SE; Young PJ; Bagshaw SM;
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35213716
[TBL] [Abstract][Full Text] [Related]
12. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
Grindlinger GA; Cairo SB; Duperre CB
J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
[TBL] [Abstract][Full Text] [Related]
13. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis.
Lee TC; Goodwin Wilson M; Lawandi A; McDonald EG
Am J Med; 2021 Mar; 134(3):e184-e188. PubMed ID: 32931766
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
Sridharan K; Sivaramakrishnan G; Gnanaraj J
Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
[TBL] [Abstract][Full Text] [Related]
16. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
18. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
He N; Yan Y; Su S; Ge Q; Zhai S
Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
Reynolds PM; MacLaren R
Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
[TBL] [Abstract][Full Text] [Related]
20. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]